Vascular and blood pressure effects of folic acid in older patients with cardiovascular disease.
Mangoni
A A
AA
Ouldred
E
E
Swif
C G
CG
Jackson
S H
SH
Draper
R P
RP
Sherwood
R A
RA
Lambert-Hammill
M
M
Wierzbicki
A S
AS
D001783:Blood Flow Velocity / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects*; D005492:Folic Acid / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D020138:Hyperhomocysteinemia / Q000097:blood / Q000150:complications* / Q000188:drug therapy* / Q000235:genetics; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D009203:Myocardial Infarction / Q000209:etiology* / Q000503:physiopathology; D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000235:genetics; D012044:Regression Analysis; D012307:Risk Factors; D012720:Severity of Illness Index; D020521:Stroke / Q000209:etiology* / Q000503:physiopathology
D005492:Folic Acid; D000587:Oxidoreductases Acting on CH-NH Group Donors; D042965:Methylenetetrahydrofolate Reductase (NADPH2)